Pfizer (PFE)

Other Income/Expenses (Net)

-$11.77B

TTM · Period ending: · USD

PFE logo

PFE Other Income/Expenses (Net)

Latest reported-$11.77B
PFE TTM Other Income/Expenses (Net) (-$959.70M → -$11.77B)
High-resolution chart · PNG

PFE other income/expenses (net) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Pfizer Other Income/Expenses (Net) — Trailing twelve months (TTM) (USD)
Period endingOther Income/Expenses (Net) (USD)
-11,767,000,000
-6,939,000,000
-7,917,000,000
-8,322,000,000
-8,359,000,000
-9,810,000,000
-9,108,000,000
-6,239,000,000
-6,332,000,000
-4,432,000,000
-3,709,000,000
-960,000,000
-1,312,000,000
-2,730,000,000
-3,308,000,000
-2,644,000,000
-1,853,000,000
608,000,000
2,482,000,000
1,568,000,000
-455,000,000
-901,000,000
-2,044,000,000
-5,229,000,000
4,059,000,000
3,482,000,000
3,568,000,000
2,919,000,000
-4,158,000,000
-3,632,000,000
-3,377,000,000
-707,000,000
-1,284,000,000
-1,806,000,000
-2,086,000,000
-2,325,000,000
-4,101,000,000
-5,426,000,000
-5,696,000,000
-6,541,000,000
-5,711,000,000
-4,470,000,000
-4,014,000,000
-1,873,000,000
-707,000,000
-593,000,000
-1,259,000,000
-1,402,000,000
-1,970,000,000
-1,055,000,000
-878,000,000
-1,800,000,000
-2,605,000,000
-4,364,000,000
-6,231,000,000
-6,678,000,000
-6,866,000,000
-6,895,000,000
-6,245,000,000
-5,788,000,000
-4,977,000,000
-5,281,000,000
-4,750,000,000
-6,644,000,000
-6,209,000,000
-5,535,000,000
-4,899,000,000
-4,915,000,000
-5,624,000,000
-5,495,000,000
-5,184,000,000
-1,351,000,000
-446,000,000
-608,000,000
-1,058,000,000
-2,335,000,000
-2,046,000,000
-1,904,000,000
-1,254,000,000
-645,000,000
-2,458,000,000
-2,508,000,000
-3,724,000,000
-4,646,000,000
-3,400,000,000
-3,115,000,000
-3,838,000,000
-4,484,000,000
-4,109,000,000
-9,193,000,000
-7,481,000,000
-5,829,000,000
-5,896,000,000
-728,000,000
-575,000,000
-564,000,000
-484,000,000
-576,000,000
-649,000,000
-855,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.